| Document, Report, or Other Product Information | |
|---|---|
| Title: | Draft NTP Technical Report on Prenatal Developmental Toxicity Studies of Vinpocetine (CAS No. 42971-09-5) in Sprague Dawley (Hsd:Sprague Dawley SD) Rats and New Zealand White (Hra:NZW SPF Rabbits (Gavage Studies) |
| Subject: | The National Toxicology Program (NTP) has conducted prenatal developmental toxicology studies in rodents of vinpocetine. Vipocetine is a man-made chemical marketed in the United States as a dietary supplement for enhanced learning, memory, and cognition and in other countries as a pharmaceutical drug. These studies were conducted to determine if there is potential harm to the developing fetus. |
| Purpose (e.g., abstract): | This draft report will be peer reviewed by an external scientific panel. Information about the peer review will be posted to the NTP website by June 5, 2019. |
| Information Product Contact | |
| ISI or HISA: | ISI |
| Is it a public panel or letter review? | |
| Link to Information Product: | |
| IC: | NIEHS |
| IC Division, Office, or Program: | Division of the National Toxicology Program |
| NIH Contact: | Mary
Wolfe 919-541-7539 [email protected] |
| Reviewer Names and Expertise: | |
| Review Description: | An external scientific panel will meet at NIEHS to peer review the draft report. |
| Date of Review: | 07/31/2019 |
| Number of Reviewers: | 6 |
| Reviewer Nominations Requested? | |
| Upcoming Panels, Events: | View Upcoming Panels, Events, Notices, Meeting Updates |
| Technical/Draft Reports, Public Comments and Presentations: | https://ntp.niehs.nih.gov/go/36051 |
| Past Roster, Notices, Meeting Updates: | View Past Roster, Notices, Meeting Updates |
| Reviewer Expertise: | general toxicology, reproductive and developmental toxicology |
| How Selected: | NTP selected from identified experts |
| Opportunity for Public Comment? | YES |
| Did any reviewers require any exception to the applicable independence or COI standards of the Bulletin, including determination by the Sec./Dep. Sec. pursuant to Section (3)(c)? | |
| Were any waivers, deferrals, exemptions, or alterative peer review processes used? | |
| Any Public Meetings? | |
| Number of Public Comments Received | |